![Thomas Lundqvist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 507 287 $ am 30.06.2026
Thomas Lundqvist was the founder of Orexo AB, established in 1994, where he held the title of Executive Vice President & Head-Orexo Innovation from 2012 to 2013.
He was also the founder of Emplicure AB, established in 2014, where he held the title of Chairman.
In addition, he worked as a Director at Xspray Pharma AB in a former job.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OREXO AB 0,58 % | 27.05.2025 | 204.567 ( 0,58 % ) | 507 287 $ | 30.06.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| XSPRAY PHARMA AB | Direktor/Vorstandsmitglied | - |
| EMPLICURE AB (PUBL) | Gründer | - |
| OREXO AB | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Xspray Pharma AB
 Xspray Pharma AB Pharmaceuticals: MajorHealth Technology Develops and produces particulate materials for the pharmaceutical industry | Health Technology |
Emplicure AB
 Emplicure AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for chronic pains | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
